Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up

作者：Eva Domingo‐Doménech, Barbara Pro, Tim Illidge, Steven M. Horwitz, Lorenz Truemper, Swaminathan P. Iyer, Ranjana H. Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Won-Seog Kim, Tatyana Feldman, Ilseung Choi, Giuseppe Gritti, David Belada, Andrei R. Shustov, Arpád Illés, Pier Luigi Zinzani, Andreas Hüttmann, Marek Trněný, Steven Le Gouill, Deepa Jagadeesh, Jonathan W. Friedberg, Meredith Little, Cassie Dong, Michelle A. Fanale, Keenan Fenton, Kerry J. Savage · 发表于：Blood Cancer Journal · 年份：2025 · DOI：10.1038/s41408-025-01329-2 · 被引用次数：5 · 研究领域：Lymphoma Diagnosis and Treatment、CNS Lymphoma Diagnosis and Treatment、Chronic Lymphocytic Leukemia Research

TRIAL REGISTRATION: ClinicalTrials.gov number: NCT01777152.